3-(4-Oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide
98%
- Product Code: 215827
CAS:
731801-19-7
Molecular Weight: | 372.4 g./mol | Molecular Formula: | C₁₇H₁₆N₄O₄S |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | 1.51±0.1 g/cm3(Predicted) | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used in pharmaceutical research as a carbonic anhydrase inhibitor with potential applications in treating glaucoma and certain types of cancer. Shows activity against tumor-associated enzyme isoforms, making it a lead compound in antitumor drug development. Also investigated for diuretic properties due to sulfamoyl group presence. Studied for its ability to cross cell membranes and inhibit intracellular carbonic anhydrase activity, supporting use in hypoxic tumor environments.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | $1,211.95 |
+
-
|
250mg | 10-20 days | $2,060.31 |
+
-
|
3-(4-Oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide
Used in pharmaceutical research as a carbonic anhydrase inhibitor with potential applications in treating glaucoma and certain types of cancer. Shows activity against tumor-associated enzyme isoforms, making it a lead compound in antitumor drug development. Also investigated for diuretic properties due to sulfamoyl group presence. Studied for its ability to cross cell membranes and inhibit intracellular carbonic anhydrase activity, supporting use in hypoxic tumor environments.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :